Venture Partners at CU Boulder News
From February 16-18, 2021, Venture Partners will host the biggest Destination Startup® yet, showcasing 25 startups from 10 different universities across six states in the Rocky Mountain region—not just Colorado—and drawing investors from around the world.
The National Academy of Inventors (NAI) has announced that CU Boulder researchers Mark Rentschler, Greg Rieker and Tin Tin Su have been designated as NAI Senior Members in recognition of their impact on society through extraordinary innovation.
From February 16-18, 2021, Venture Partners will host the biggest Destination Startup® yet, showcasing 26 startups from 10 different universities across six states in the Rocky Mountain region—not just Colorado—and drawing investors from around the world.
Judges from the local entrepreneurial ecosystem awarded a record total of 12 grants—up to $125,000 each—for the top physical science, engineering and bioscience innovations demonstrating high commercial potential, a clear path to a compelling market and strong scientific support.
Through the Lab Venture Challenge, Venture Partners at CU Boulder funds the university's top innovations addressing a commercial need, with a clear path to a compelling market and strong scientific support. This showcase is a can't-miss event to see breakthrough innovations.
Bristol Myers Squibb acquires MyoKardia, co-founded by CU Boulder faculty, for $13.1 billion in cashMyoKardia, a clinical-stage biopharmaceutical company discovering and developing targeted therapies for the treatment of serious cardiovascular diseases, was co-founded by Leslie Leinwand, Distinguished Professor of Molecular, Cellular, and Developmental Biology at CU Boulder's BioFrontiers Institute.
In September, the Yidan Prize Foundation awarded Carl Wieman the prestigious Yidan Prize in Education Research for his “contribution in developing new techniques and tools in STEM education.” Wieman will use prize and project money to support CU Boulder’s award-winning PhET Interactive Simulations.
Step 1: Create a vaccine for COVID-19. Step 2: Distribute it across the world. This second step may be even more challenging than the first, which is why CU Boulder researchers and spinoff VitriVax are focused on finding a way to get vaccines to 7.8 billion people.
The robotics spinout company of CU Boulder’s Paul M. Rady Department of Mechanical Engineering, will use the award to further their research into the unique electromechanical failure mechanism in HASEL actuators, a new class of smart, soft, high-speed robotic hardware.
Venture Partners at CU Boulder is identifying new innovations that address problems related to the COVID-19 pandemic. To ensure that COVID-19 innovations are rapidly brought to those who need them most, Venture Partners will be adopting an “Open Access” licensing strategy.